Safety and efficacy of ashwagen (a standardized withania somnifera extract) in stress and anxiety with hypertension and associated cardiometabolic risk factors: a randomized, placebo-controlled trial.

StressMay 9, 2026 (epub)
Clinical ResearchPsychiatryCardiologyEndocrinology

Amrit Pattojoshi, Sudeep Kumar Patra, S A Idrees et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized, double-blind, placebo-controlled Phase III trial evaluated the safety and efficacy of Ashwagen®, a standardized Withania somnifera extract, in 60 patients with stress, anxiety, and pre-existing hypertension. The study found that Ashwagen® significantly reduced anxiety and stress markers, with HAM-A, GAD-7, and PSS scores decreasing by 26.94%, 50.77%, and 30.47%, respectively, compared to placebo.

Key findings

  • HAM-A, GAD-7, and PSS scores decreased by 26.94%, 50.77%, and 30.47% in the Ashwagen® group.
  • Cortisol levels declined by 28.99% in patients taking Ashwagen®.
  • Triglycerides decreased by 13.00% with Ashwagen® treatment.
  • No serious adverse events were reported during the trial.

Why it matters

The findings suggest that Ashwagen® may serve as a safe and effective adjunctive treatment for managing stress and anxiety in patients with hypertension, addressing both psychological and physiological aspects of these conditions.

Source

PubMed · PMID 42105298

Published in Stress. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.